| | Verschil (%) | Varia. 5d. | Vaira. 1 jan. | Varia. 1j. | Varia. 3j. | Kapi. (M$) |
 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -1.52% | -0.35% | -8.27% | 3.49% | 49.36% | 8 964 |
| | | | | | | |
 | CSL LIMITED | -1.12% | 6.48% | 7.18% | 21.14% | -3.62% | 105 379 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.49% | 1.77% | -1.71% | 4.94% | 55.49% | 46 422 |
 | BIOGEN INC. | 1.64% | -2.22% | 4.10% | 30.13% | -14.52% | 40 843 |
 | WUXI BIOLOGICS (CAYMAN) INC. | 1.73% | -7.05% | 7.94% | -19.85% | 79.11% | 35 517 |
| CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -1.86% | -2.11% | 9.05% | -9.32% | 45.94% | 23 092 |
| BIOMARIN PHARMACEUTICAL INC. | -0.02% | -4.32% | 8.40% | 26.57% | 26.23% | 20 852 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -2.82% | -4.04% | 1.55% | -16.69% | --.--% | 17 738 |
 | UCB | 1.57% | 1.38% | 3.70% | -13.61% | -12.82% | 15 481 |
| WALVAX BIOTECHNOLOGY CO., LTD. | -2.27% | -1.10% | -1.64% | -17.99% | 37.35% | 9 566 |
| INNOVENT BIOLOGICS, INC. | 1.40% | -2.98% | 29.40% | 36.97% | 36.75% | 8 918 |
 | GRIFOLS, S.A. | -0.84% | 10.95% | 25.63% | -10.69% | -57.21% | 8 830 |
| CELLTRION HEALTHCARE CO., LTD. | -1.66% | 3.67% | 2.24% | -4.53% | 8.94% | 7 823 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -1.59% | -6.49% | -23.30% | -18.69% | 55.00% | 7 557 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 0.85% | 1.04% | 9.41% | 26.03% | 32.92% | 6 592 |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | -1.44% | -0.64% | -2.52% | -8.17% | -37.83% | 6 250 |
| | | | | | | |
| | Gemiddelde | -0.46% | -0.38% | 5.30% | 1.75% | 17.98% | |
| | Gewogen gemiddelde per kap. | -0.35% | 0.77% | 5.42% | 7.82% | 18.85% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
